Clinical trial
Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy
NCT04711330
Study timeline
Study start (actual)2022-09-01Date precision: day
Registry last updated2025-10-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancer Stage IIIunresolved
Immunotherapyunresolved
Interventions
Sponsors & collaborators
Leiden University Medical Centerlead sponsor
The Netherlands Cancer Institutecollaborator
Jessa Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04711330 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.